Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress
- 2 November 2014
- journal article
- video audio-media
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 20 (12), 1417-1426
- https://doi.org/10.1038/nm.3705
Abstract
In type 2 diabetes, hyperglycemia is present when an increased demand for insulin, typically due to insulin resistance, is not met as a result of progressive pancreatic beta cell dysfunction. This defect in beta cell activity is typically characterized by impaired insulin biosynthesis and secretion, usually accompanied by oxidative and endoplasmic reticulum (ER) stress. We demonstrate that multiple inflammatory cytokines elevated in diabetic pancreatic islets induce beta cell oxidative and ER stress, with interleukin-23 (IL-23), IL-24 and IL-33 being the most potent. Conversely, we show that islet-endogenous and exogenous IL-22, by regulating oxidative stress pathways, suppresses oxidative and ER stress caused by cytokines or glucolipotoxicity in mouse and human beta cells. In obese mice, antibody neutralization of IL-23 or IL-24 partially reduced beta cell ER stress and improved glucose tolerance, whereas IL-22 administration modulated oxidative stress regulatory genes in islets, suppressed ER stress and inflammation, promoted secretion of high-quality efficacious insulin and fully restored glucose homeostasis followed by restitution of insulin sensitivity. Thus, therapeutic manipulation of immune regulators of beta cell stress reverses the hyperglycemia central to diabetes pathology.Keywords
This publication has 67 references indexed in Scilit:
- Allosteric Inhibition of the IRE1α RNase Preserves Cell Viability and Function during Endoplasmic Reticulum StressCell, 2014
- Elevated Peripheral Frequencies of Th22 Cells: A Novel Potent Participant in Obesity and Type 2 DiabetesPLOS ONE, 2014
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsThe Lancet, 2013
- Lymphotoxin regulates commensal responses to enable diet-induced obesityNature Immunology, 2012
- Endoplasmic Reticulum Stress and Type 2 DiabetesAnnual Review of Biochemistry, 2012
- Regulation of pancreatic β-cell survival by nitric oxideIslets, 2012
- Diabetes Mellitus and the β Cell: The Last Ten YearsCell, 2012
- Dual and opposing roles of the unfolded protein response regulated by IRE1α and XBP1 in proinsulin processing and insulin secretionProceedings of the National Academy of Sciences of the United States of America, 2011
- The endoplasmic reticulum stress response in the pancreatic β‐cellDiabetes, Obesity and Metabolism, 2010
- Cytokines Downregulate the Sarcoendoplasmic Reticulum Pump Ca2+ ATPase 2b and Deplete Endoplasmic Reticulum Ca2+, Leading to Induction of Endoplasmic Reticulum Stress in Pancreatic β-CellsDiabetes, 2005